These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 19610180)

  • 1. Pharma industry's bitter pill ... could be impetus for devicemaker legislation, too.
    Blesch G
    Mod Healthc; 2009 Mar; 39(10):11. PubMed ID: 19610180
    [No Abstract]   [Full Text] [Related]  

  • 2. Permitting product liability litigation for FDA-approved drugs and devices promotes patient safety.
    Kesselheim AS
    Clin Pharmacol Ther; 2010 Jun; 87(6):645-7. PubMed ID: 20485322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Good law from tragic facts--Congress, the FDA, and preemption.
    Annas GJ
    N Engl J Med; 2009 Sep; 361(12):1206-11. PubMed ID: 19759383
    [No Abstract]   [Full Text] [Related]  

  • 4. Legal Liability of Generic vs Brand Drug Manufacturers for Inadequate Product Labels.
    Boumil MM; Curfman G
    JAMA; 2018 Aug; 320(6):547-548. PubMed ID: 30039167
    [No Abstract]   [Full Text] [Related]  

  • 5. On access and accountability--two Supreme Court rulings on generic drugs.
    Boumil MM; Curfman GD
    N Engl J Med; 2013 Aug; 369(8):696-7. PubMed ID: 23923990
    [No Abstract]   [Full Text] [Related]  

  • 6. The Medical Device Safety Act of 2009.
    Curfman GD; Morrissey S; Drazen JM
    N Engl J Med; 2009 Apr; 360(15):1550-1. PubMed ID: 19297562
    [No Abstract]   [Full Text] [Related]  

  • 7. Prescriptions, privacy, and the First Amendment.
    Curfman GD; Morrissey S; Drazen JM
    N Engl J Med; 2011 May; 364(21):2053-5. PubMed ID: 21524208
    [No Abstract]   [Full Text] [Related]  

  • 8. Tort litigation and federal regulation of medical devices.
    Piwinski S; Fitzpatrick S
    JAMA; 2008 Oct; 300(16):1881-2; author reply 1882. PubMed ID: 18940973
    [No Abstract]   [Full Text] [Related]  

  • 9. Risk, responsibility, and generic drugs.
    Kesselheim AS; Avorn J; Greene JA
    N Engl J Med; 2012 Nov; 367(18):1679-81. PubMed ID: 23113477
    [No Abstract]   [Full Text] [Related]  

  • 10. Impossible? Outlawing state safety laws for generic drugs.
    Glantz LH; Annas GJ
    N Engl J Med; 2011 Aug; 365(8):681-3. PubMed ID: 21830958
    [No Abstract]   [Full Text] [Related]  

  • 11. Why doctors should worry about preemption.
    Curfman GD; Morrissey S; Drazen JM
    N Engl J Med; 2008 Jul; 359(1):1-3. PubMed ID: 18596269
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmaceuticals and medical devices: FDA oversight. End-of-year issue brief.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2010 Jan; ():1-31. PubMed ID: 20217914
    [No Abstract]   [Full Text] [Related]  

  • 13. Wyeth v Levine: implications for public health policy and practice.
    David S; Rosenbaum S
    Public Health Rep; 2010; 125(3):494-7. PubMed ID: 20433045
    [No Abstract]   [Full Text] [Related]  

  • 14. The deregulatory effects of preempting tort litigation: FDA regulation of medical devices.
    Gostin LO
    JAMA; 2008 May; 299(19):2313-6. PubMed ID: 18492972
    [No Abstract]   [Full Text] [Related]  

  • 15. The Supreme Court, preemption, and malpractice liability.
    Kesselheim AS; Studdert DM
    N Engl J Med; 2009 Feb; 360(6):559-61. PubMed ID: 19196672
    [No Abstract]   [Full Text] [Related]  

  • 16. Higher First Amendment hurdles for public health regulation.
    Outterson K
    N Engl J Med; 2011 Aug; 365(7):e13. PubMed ID: 21812665
    [No Abstract]   [Full Text] [Related]  

  • 17. Recent developments in health law. Wyeth v. Levine: challenging implied pre-emption for drugs.
    Nair P
    J Law Med Ethics; 2009; 37(3):527-30. PubMed ID: 19791315
    [No Abstract]   [Full Text] [Related]  

  • 18. Abortion choice and the law in Vermont: a recent study.
    Olmstead FH
    Vt Law Rev; 1982; 7(2):281-313. PubMed ID: 11655820
    [No Abstract]   [Full Text] [Related]  

  • 19. FDA's regulation of prescription drug labeling: a role for implied preemption.
    Kendrick LC
    Food Drug Law J; 2007; 62(1):227-47. PubMed ID: 17444031
    [No Abstract]   [Full Text] [Related]  

  • 20. The FDA, preemption, and the Supreme Court.
    Glantz LH; Annas GJ
    N Engl J Med; 2008 May; 358(18):1883-5. PubMed ID: 18450601
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.